Latest Strategic Refocus News

Page 3 of 12
Aeris Resources has finalised the sale of its North Queensland copper assets to Dingo Minerals, unlocking immediate cash and environmental bond releases with further payments contingent on production milestones.
Maxwell Dee
Maxwell Dee
26 Mar 2026
Alchemy Resources has agreed to sell its Karonie and Lake Rebecca gold projects to Forrestania Resources for $5 million in shares, while retaining a 1% royalty. This deal marks a strategic refocus on Alchemy’s promising New South Wales assets.
Maxwell Dee
Maxwell Dee
11 Mar 2026
ActivEX Limited has fully repaid its $2.3 million loan to Star Diamond Developments by transferring full ownership of its East Coast Gold and Copper subsidiary, leaving the company debt free and financially strengthened.
Maxwell Dee
Maxwell Dee
10 Mar 2026
Kingfisher Mining has agreed to sell its Gascoyne rare earth elements project to Dreadnought Resources for $2 million in shares plus milestone payments, freeing capital to advance its copper-gold portfolio in New South Wales.
Maxwell Dee
Maxwell Dee
2 Mar 2026
Opthea Limited reports a striking turnaround with a $339.9 million profit for H1 2026, driven by a strategic refocus on developing OPT-302 for Lymphangioleiomyomatosis (LAM), a rare lung disease affecting women. The company plans a rebrand and ASX reinstatement as it charts a new course in rare respiratory health.
Ada Torres
Ada Torres
2 Mar 2026
Nexion Group Ltd reports a striking turnaround to a $6.3 million net profit in H1 2026, driven by gains from subsidiary sales, while continuing operations still face losses amid efforts to regain ASX trading status.
Sophie Babbage
Sophie Babbage
27 Feb 2026
HALO Technologies reports a strategic pivot towards APAC growth and a UK business model overhaul, alongside a 16% revenue decline and increased net loss in FY25.
Claire Turing
Claire Turing
27 Feb 2026
Epsilon Healthcare Limited has reported a robust recovery in 2025, with revenue climbing 68% to $9.39 million and net losses shrinking by 63%, driven by growth in contract manufacturing and a new pharmacy division.
Ada Torres
Ada Torres
27 Feb 2026
Percheron Therapeutics reports a 64% reduction in half-year losses to $3.1 million, driven by progress in its licensed immuno-oncology drug HMBD-002 and a strategic pivot away from discontinued assets.
Ada Torres
Ada Torres
26 Feb 2026
Energy World Corporation has eliminated all group-level borrowings, strengthening its balance sheet and advancing key LNG and power projects in Southeast Asia amid ongoing operational losses.
Maxwell Dee
Maxwell Dee
25 Feb 2026
White Cliff Minerals has agreed to sell its Great Bear Project in Canada for A$5.8 million, while announcing key board appointments to support its next growth phase.
Maxwell Dee
Maxwell Dee
23 Feb 2026
Aristocrat Leisure reported robust FY25 results with double-digit revenue and profit growth, underpinned by strategic divestments and investments in AI. The company’s FY26 outlook remains positive, driven by market share gains and new product launches.
Victor Sage
Victor Sage
19 Feb 2026